Ayman Naser, Surgical Oncologist at Ministry of Health – Jordan, shared a post on LinkedIn:
“I am incredibly honored and delighted to have met Prof. Dr. Salah-Eddin Al-Batran, at a recent advisory board meeting hosted by AstraZeneca.
Meeting a leading figure whose work heavily influences modern gastric cancer protocols was a definitive highlight.
The forum provided an excellent opportunity to discuss the current management and future treatment perspectives for resectable gastric and GEJ cancers.
Exchanging strategic insights in this setting offers invaluable momentum as we continuously strive to optimize patient outcomes and refine multidisciplinary care.”
Other articles about gastric cancer on OncoDaily.